OLOPATADINE HYDROCHLORIDE OPHTHALMIC

OLOPATADINE HYDROCHLORIDE OPHTHALMIC was reported 4099 times

These side effects are most commonly reported by patients taking OLOPATADINE HYDROCHLORIDE OPHTHALMIC:

# Side effect Count
0 TREATMENT FAILURE 1933
1 DRUG INEFFECTIVE 265
2 HEADACHE 118
3 NAUSEA 117
4 DIARRHOEA 114
5 FATIGUE 104
6 PYREXIA 104
7 PNEUMONIA 103
8 MALAISE 99
9 RASH 97
10 DYSPNOEA 92
11 PAIN 92
12 PRURITUS 90
13 COUGH 89
14 SINUSITIS 85
15 HYPERSENSITIVITY 83
16 ARTHRALGIA 79
17 DIZZINESS 77
18 OFF LABEL USE 76
19 PRODUCT DOSE OMISSION ISSUE 73
20 VOMITING 68
21 NASOPHARYNGITIS 64
22 ASTHMA 61
23 EYE IRRITATION 56
24 WEIGHT INCREASED 56
25 DECREASED APPETITE 53
26 URINARY TRACT INFECTION 53
27 COVID-19 52
28 EYE PAIN 51
29 WEIGHT DECREASED 50
30 BRONCHITIS 49
31 INFLUENZA 49
32 CONDITION AGGRAVATED 48
33 FALL 48
34 PAIN IN EXTREMITY 47
35 INSOMNIA 46
36 ANAEMIA 45
37 ERYTHEMA 45
38 ASTHENIA 43
39 EYE PRURITUS 43
40 BACK PAIN 42
41 FEELING ABNORMAL 42
42 PLATELET COUNT DECREASED 41
43 HEPATIC FUNCTION ABNORMAL 40
44 ILLNESS 39
45 VISION BLURRED 39
46 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38
47 RENAL IMPAIRMENT 38
48 DRY EYE 37
49 PRODUCT USE IN UNAPPROVED INDICATION 37
50 OCULAR HYPERAEMIA 36
51 PRODUCT USE ISSUE 36
52 PRODUCTIVE COUGH 36
53 HYPERTENSION 35
54 INTERSTITIAL LUNG DISEASE 35
55 ANXIETY 34
56 DEATH 34
57 DRUG HYPERSENSITIVITY 34
58 NO ADVERSE EVENT 34
59 PRODUCT DELIVERY MECHANISM ISSUE 34
60 ABDOMINAL PAIN 33
61 CONSTIPATION 33
62 RHINORRHOEA 33
63 URTICARIA 33
64 FEBRILE NEUTROPENIA 32
65 INJECTION SITE PAIN 32
66 WHITE BLOOD CELL COUNT DECREASED 32
67 DRUG ERUPTION 30
68 HYPOTENSION 30
69 JOINT SWELLING 29
70 DEHYDRATION 28
71 INFUSION RELATED REACTION 28
72 BLOOD PRESSURE DECREASED 27
73 BLOOD PRESSURE INCREASED 27
74 CARDIAC DISORDER 27
75 GAIT DISTURBANCE 27
76 MUSCLE SPASMS 27
77 SEPSIS 27
78 CELLULITIS 26
79 CHEST DISCOMFORT 26
80 CHEST PAIN 26
81 DRY SKIN 26
82 NASAL CONGESTION 26
83 OROPHARYNGEAL PAIN 26
84 BLOOD CHOLESTEROL INCREASED 25
85 CARDIAC FAILURE 25
86 CONJUNCTIVITIS 25
87 OEDEMA PERIPHERAL 25
88 PERIPHERAL SWELLING 25
89 SEASONAL ALLERGY 25
90 BLOOD PRESSURE FLUCTUATION 24
91 HEART RATE INCREASED 24
92 NEUTROPHIL COUNT DECREASED 24
93 VIRAL INFECTION 24
94 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24
95 ABDOMINAL PAIN UPPER 23
96 DEPRESSION 23
97 ECZEMA 23
98 HERPES ZOSTER 23
99 MIGRAINE 23
100 ANAPHYLACTIC REACTION 22
101 EPISTAXIS 22
102 HYPOAESTHESIA 22
103 INFLUENZA LIKE ILLNESS 22
104 MALIGNANT NEOPLASM PROGRESSION 22
105 EAR INFECTION 21
106 ERYTHEMA MULTIFORME 21
107 FUNGAL INFECTION 21
108 INFECTION 21
109 LIVER DISORDER 21
110 MYALGIA 21
111 PALPITATIONS 21
112 INFUSION SITE ERYTHEMA 20
113 INFUSION SITE PAIN 20
114 MUSCULAR WEAKNESS 20
115 OXYGEN SATURATION DECREASED 20
116 DIVERTICULITIS 19
117 DYSPNOEA EXERTIONAL 19
118 INCORRECT DOSE ADMINISTERED 19
119 ACUTE KIDNEY INJURY 18
120 ATRIAL FIBRILLATION 18
121 GASTROOESOPHAGEAL REFLUX DISEASE 18
122 HAEMOGLOBIN DECREASED 18
123 PNEUMONIA ASPIRATION 18
124 RHEUMATOID ARTHRITIS 18
125 SKIN ULCER 18
126 WHEEZING 18
127 ALANINE AMINOTRANSFERASE INCREASED 17
128 EYE SWELLING 17
129 GENERAL PHYSICAL HEALTH DETERIORATION 17
130 OVERDOSE 17
131 TREMOR 17
132 UPPER RESPIRATORY TRACT INFECTION 17
133 ABDOMINAL DISCOMFORT 16
134 BLOOD PRESSURE SYSTOLIC ABNORMAL 16
135 HEPATIC ENZYME INCREASED 16
136 LACRIMATION INCREASED 16
137 NEUTROPENIA 16
138 OEDEMA 16
139 PARAESTHESIA 16
140 PRODUCT SUBSTITUTION ISSUE 16
141 SKIN EXFOLIATION 16
142 SWELLING 16
143 TACHYCARDIA 16
144 VISUAL IMPAIRMENT 16
145 ABDOMINAL DISTENSION 15
146 ADRENAL INSUFFICIENCY 15
147 ALOPECIA 15
148 BLOOD PRESSURE SYSTOLIC INCREASED 15
149 C-REACTIVE PROTEIN INCREASED 15
150 CARDIAC FAILURE CONGESTIVE 15
151 CATARACT 15
152 CHILLS 15
153 DRUG-INDUCED LIVER INJURY 15
154 HYPOKALAEMIA 15
155 INJECTION SITE ERYTHEMA 15
156 MYOCARDIAL INFARCTION 15
157 NEURALGIA 15
158 PEMPHIGOID 15
159 SOMNOLENCE 15
160 THROMBOCYTOPENIA 15
161 ASPARTATE AMINOTRANSFERASE INCREASED 14
162 EYE DISCHARGE 14
163 HYPERHIDROSIS 14
164 INFUSION SITE SWELLING 14
165 INJECTION SITE PRURITUS 14
166 INJECTION SITE SWELLING 14
167 MULTIPLE ALLERGIES 14
168 NECK PAIN 14
169 RENAL FAILURE 14
170 ALTERED STATE OF CONSCIOUSNESS 13
171 DERMATITIS ATOPIC 13
172 DISSEMINATED INTRAVASCULAR COAGULATION 13
173 FLUSHING 13
174 HOT FLUSH 13
175 PLEURAL EFFUSION 13
176 SEPTIC SHOCK 13
177 THERAPY NON-RESPONDER 13
178 TINNITUS 13
179 BACTERIAL INFECTION 12
180 CEREBRAL INFARCTION 12
181 CHOLANGITIS 12
182 CONJUNCTIVITIS ALLERGIC 12
183 DRUG INTERACTION 12
184 EYE INFECTION 12
185 HYPOXIA 12
186 INFUSION SITE PRURITUS 12
187 LOSS OF CONSCIOUSNESS 12
188 LUNG DISORDER 12
189 NEUROPATHY PERIPHERAL 12
190 PANCYTOPENIA 12
191 PULMONARY MASS 12
192 SLEEP DISORDER 12
193 STAPHYLOCOCCAL INFECTION 12
194 TYPE 2 DIABETES MELLITUS 12
195 BURNING SENSATION 11
196 CONTRAINDICATED PRODUCT ADMINISTERED 11
197 CONTUSION 11
198 DEPRESSED LEVEL OF CONSCIOUSNESS 11
199 DEVICE LEAKAGE 11
200 DYSPHAGIA 11
201 EYE DISORDER 11
202 GASTROINTESTINAL DISORDER 11
203 HAEMORRHAGE 11
204 HYPOTHYROIDISM 11
205 LOCALISED INFECTION 11
206 OCULAR DISCOMFORT 11
207 PHARYNGITIS 11
208 PRODUCT QUALITY ISSUE 11
209 PSORIASIS 11
210 RESPIRATORY TRACT INFECTION 11
211 SEIZURE 11
212 STEVENS-JOHNSON SYNDROME 11
213 ARTHRITIS 10
214 BODY TEMPERATURE DECREASED 10
215 CANDIDA INFECTION 10
216 CYTOKINE RELEASE SYNDROME 10
217 DELIRIUM 10
218 DYSPEPSIA 10
219 EAR PAIN 10
220 GASTRITIS 10
221 INFUSION SITE HAEMORRHAGE 10
222 INTENTIONAL DOSE OMISSION 10
223 INTENTIONAL PRODUCT USE ISSUE 10
224 LIMB INJURY 10
225 MELAENA 10
226 MEMORY IMPAIRMENT 10
227 PULMONARY ARTERIAL HYPERTENSION 10
228 RASH ERYTHEMATOUS 10
229 RENAL COLIC 10
230 SURGERY 10
231 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10
232 THERAPEUTIC RESPONSE SHORTENED 10
233 UNDERDOSE 10
234 URINARY RETENTION 10
235 BLISTER 9
236 BLOOD CREATINE PHOSPHOKINASE INCREASED 9
237 BLOOD CREATININE INCREASED 9
238 BLOOD LACTATE DEHYDROGENASE INCREASED 9
239 CYSTITIS 9
240 DEEP VEIN THROMBOSIS 9
241 DIABETES MELLITUS 9
242 HEPATIC FAILURE 9
243 HYPERURICAEMIA 9
244 HYPOPHAGIA 9
245 INFUSION SITE BRUISING 9
246 LIP SWELLING 9
247 LYMPHADENOPATHY 9
248 MOBILITY DECREASED 9
249 MYELODYSPLASTIC SYNDROME 9
250 MYELOSUPPRESSION 9
251 ORAL CANDIDIASIS 9
252 OSTEOPOROSIS 9
253 PRESCRIBED UNDERDOSE 9
254 RESPIRATORY DISORDER 9
255 RHINITIS ALLERGIC 9
256 SJOGREN^S SYNDROME 9
257 THERAPEUTIC PRODUCT EFFECT DECREASED 9
258 WOUND 9
259 ACCIDENTAL EXPOSURE TO PRODUCT 8
260 BLOOD BILIRUBIN INCREASED 8
261 BLOOD PRESSURE DIASTOLIC INCREASED 8
262 CEREBRAL HAEMORRHAGE 8
263 CEREBROVASCULAR ACCIDENT 8
264 COMA 8
265 DERMATITIS CONTACT 8
266 DERMATITIS EXFOLIATIVE GENERALISED 8
267 DISCOMFORT 8
268 DYSPHONIA 8
269 FEELING HOT 8
270 GASTROENTERITIS 8
271 GASTROINTESTINAL HAEMORRHAGE 8
272 HALLUCINATION 8
273 HEPATIC STEATOSIS 8
274 INFLAMMATION 8
275 INFUSION SITE DISCHARGE 8
276 INJECTION SITE EXTRAVASATION 8
277 LEUKOPENIA 8
278 LIGAMENT SPRAIN 8
279 MIDDLE INSOMNIA 8
280 MUSCULOSKELETAL STIFFNESS 8
281 ORAL HERPES 8
282 PNEUMOTHORAX 8
283 POOR VENOUS ACCESS 8
284 PRESYNCOPE 8
285 PRODUCT PACKAGING QUANTITY ISSUE 8
286 RASH GENERALISED 8
287 RESTLESS LEGS SYNDROME 8
288 RHABDOMYOLYSIS 8
289 SINUS DISORDER 8
290 SKIN FISSURES 8
291 SPINAL COMPRESSION FRACTURE 8
292 TASTE DISORDER 8
293 ACUTE MYELOID LEUKAEMIA 7
294 ADVERSE DRUG REACTION 7
295 ANAPHYLACTIC SHOCK 7
296 ARTHROPATHY 7
297 BLINDNESS 7
298 BLOOD GLUCOSE ABNORMAL 7
299 BRAIN FOG 7
300 BREATH SOUNDS ABNORMAL 7
301 CONFUSIONAL STATE 7
302 DEAFNESS 7
303 DEVICE DEFECTIVE 7
304 DEVICE INFUSION ISSUE 7
305 DISEASE PROGRESSION 7
306 DRY MOUTH 7
307 EMOTIONAL DISTRESS 7
308 EOSINOPHIL COUNT INCREASED 7
309 EXPIRED PRODUCT ADMINISTERED 7
310 FEEDING DISORDER 7
311 FLUID RETENTION 7
312 FOOD POISONING 7
313 HAEMATOCHEZIA 7
314 INJECTION SITE BRUISING 7
315 INJURY 7
316 INSURANCE ISSUE 7
317 INTERNATIONAL NORMALISED RATIO INCREASED 7
318 INTESTINAL OBSTRUCTION 7
319 IRRITABILITY 7
320 KIDNEY INFECTION 7
321 MITRAL VALVE DISEASE 7
322 MUSCULOSKELETAL PAIN 7
323 NEPHROLITHIASIS 7
324 OSTEOARTHRITIS 7
325 PHOTOPHOBIA 7
326 POLLAKIURIA 7
327 POLYP 7
328 PRODUCT ADMINISTRATION ERROR 7
329 PRODUCT ADMINISTRATION INTERRUPTED 7
330 PRODUCT AVAILABILITY ISSUE 7
331 PRODUCT DOSE OMISSION IN ERROR 7
332 PRODUCT USE COMPLAINT 7
333 PSEUDOMONAS INFECTION 7
334 RASH MACULAR 7
335 RESPIRATORY FAILURE 7
336 SECRETION DISCHARGE 7
337 SINUS CONGESTION 7
338 STOMATITIS 7
339 STRESS 7
340 SUICIDE ATTEMPT 7
341 SYSTEMIC LUPUS ERYTHEMATOSUS 7
342 THERAPEUTIC RESPONSE DECREASED 7
343 TOOTH INFECTION 7
344 TOOTHACHE 7
345 TREATMENT NONCOMPLIANCE 7
346 TUBULOINTERSTITIAL NEPHRITIS 7
347 URTICARIAL VASCULITIS 7
348 UVEITIS 7
349 VERTIGO 7
350 ABNORMAL BEHAVIOUR 6
351 AGGRESSION 6
352 APHTHOUS ULCER 6
353 ASCITES 6
354 AUTOIMMUNE DISORDER 6
355 BALANCE DISORDER 6
356 BLOOD GLUCOSE INCREASED 6
357 BLOOD PRESSURE SYSTOLIC DECREASED 6
358 BODY HEIGHT DECREASED 6
359 BREAST CANCER 6
360 BRONCHIECTASIS 6
361 CARDIO-RESPIRATORY ARREST 6
362 CHRONIC KIDNEY DISEASE 6
363 CRYING 6
364 DEVICE ISSUE 6
365 DEVICE RELATED INFECTION 6
366 DRUG DOSE OMISSION 6
367 DRUG EFFECT LESS THAN EXPECTED 6
368 DRUG INTOLERANCE 6
369 EYELID INFECTION 6
370 FEAR 6
371 FIBROMYALGIA 6
372 FOOT FRACTURE 6
373 GASTRIC ULCER 6
374 GASTROINTESTINAL INFECTION 6
375 HAEMATEMESIS 6
376 HAEMOPTYSIS 6
377 HAEMORRHOIDS 6
378 HEREDITARY ANGIOEDEMA 6
379 HYPERKALAEMIA 6
380 HYPOGAMMAGLOBULINAEMIA 6
381 HYPONATRAEMIA 6
382 ILL-DEFINED DISORDER 6
383 INJECTION SITE MASS 6
384 JAUNDICE 6
385 LACTIC ACIDOSIS 6
386 LIGAMENT RUPTURE 6
387 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6
388 OROPHARYNGEAL DISCOMFORT 6
389 PAIN OF SKIN 6
390 PERICARDIAL EFFUSION 6
391 PHARYNGITIS STREPTOCOCCAL 6
392 PNEUMOCYSTIS JIROVECII PNEUMONIA 6
393 PNEUMONIA BACTERIAL 6
394 PRODUCT PACKAGING DIFFICULT TO OPEN 6
395 PULMONARY OEDEMA 6
396 RASH MACULO-PAPULAR 6
397 RASH PRURITIC 6
398 RESTLESSNESS 6
399 SCAB 6
400 SCIATICA 6
401 SKIN EROSION 6
402 SLEEP APNOEA SYNDROME 6
403 SUICIDAL IDEATION 6
404 THERAPY INTERRUPTED 6
405 THIRST 6
406 UPPER RESPIRATORY TRACT INFLAMMATION 6
407 VEIN COLLAPSE 6
408 ACCIDENTAL OVERDOSE 5
409 ADVERSE EVENT 5
410 AGITATION 5
411 ALOPECIA AREATA 5
412 AMNESIA 5
413 BLOOD ALKALINE PHOSPHATASE INCREASED 5
414 BLOOD COUNT ABNORMAL 5
415 BLOOD IMMUNOGLOBULIN G DECREASED 5
416 BLOOD POTASSIUM DECREASED 5
417 BLOOD PRESSURE DIASTOLIC ABNORMAL 5
418 BLOOD UREA INCREASED 5
419 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5
420 CHRONIC SINUSITIS 5
421 CLOSTRIDIUM DIFFICILE INFECTION 5
422 COMPLETED SUICIDE 5
423 COVID-19 PNEUMONIA 5
424 CYTOMEGALOVIRUS INFECTION 5
425 DEVICE BREAKAGE 5
426 DYSGEUSIA 5
427 DYSKINESIA 5
428 EAR DISORDER 5
429 ELECTROCARDIOGRAM QT PROLONGED 5
430 ENCEPHALOPATHY 5
431 ENTERITIS INFECTIOUS 5
432 ERYTHEMA OF EYELID 5
433 EXPOSURE TO ALLERGEN 5
434 EYE ALLERGY 5
435 EYELID OEDEMA 5
436 FAECES DISCOLOURED 5
437 FEELING JITTERY 5
438 FEMUR FRACTURE 5
439 FOREIGN BODY SENSATION IN EYES 5
440 GAIT INABILITY 5
441 HAEMATURIA 5
442 HEAD INJURY 5
443 HEART RATE DECREASED 5
444 HERPES VIRUS INFECTION 5
445 HUMIDITY INTOLERANCE 5
446 HYPERGLYCAEMIA 5
447 HYPOGLYCAEMIA 5
448 ILEUS 5
449 IMMUNE-MEDIATED ENTEROCOLITIS 5
450 IMMUNE-MEDIATED HEPATIC DISORDER 5
451 INCORRECT PRODUCT ADMINISTRATION DURATION 5
452 INCREASED UPPER AIRWAY SECRETION 5
453 INFUSION SITE REACTION 5
454 INJECTION SITE HAEMORRHAGE 5
455 INJECTION SITE REACTION 5
456 INTESTINAL PERFORATION 5
457 LABORATORY TEST ABNORMAL 5
458 LIP EROSION 5
459 MITRAL VALVE INCOMPETENCE 5
460 MUSCLE STRAIN 5
461 MYOFASCIAL PAIN SYNDROME 5
462 NEOPLASM 5
463 NEOPLASM MALIGNANT 5
464 NERVOUSNESS 5
465 PALLOR 5
466 PANCREATITIS 5
467 PANIC ATTACK 5
468 PERIPHERAL SENSORY NEUROPATHY 5
469 PNEUMONIA INFLUENZAL 5
470 POST PROCEDURAL INFECTION 5
471 PRODUCT DISTRIBUTION ISSUE 5
472 PRODUCT DOSE OMISSION 5
473 PROTEINURIA 5
474 PULMONARY CONGESTION 5
475 PYELONEPHRITIS ACUTE 5
476 RENAL DISORDER 5
477 RESPIRATORY SYMPTOM 5
478 RESPIRATORY TRACT INFECTION VIRAL 5
479 RHINITIS 5
480 SARS-COV-2 TEST POSITIVE 5
481 SINUS HEADACHE 5
482 SKIN DISCOLOURATION 5
483 SKIN HAEMORRHAGE 5
484 SKIN IRRITATION 5
485 SNEEZING 5
486 SWELLING FACE 5
487 SWELLING OF EYELID 5
488 THERAPEUTIC PRODUCT INEFFECTIVE 5
489 THERMAL BURN 5
490 THROAT IRRITATION 5
491 TOTAL CHOLESTEROL/HDL RATIO ABNORMAL 5
492 VASCULAR DEVICE INFECTION 5
493 WHITE BLOOD CELL COUNT INCREASED 5
494 AMYLASE INCREASED 4
495 ANKLE FRACTURE 4
496 APPENDICITIS 4
497 ARRHYTHMIA 4
498 ARTERIOSCLEROSIS 4
499 ASPHYXIA 4
500 ATAXIA 4
501 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 4
502 BACK DISORDER 4
503 BACTERAEMIA 4
504 BLOOD IRON DECREASED 4
505 BLOOD PRESSURE ABNORMAL 4
506 BRADYCARDIA 4
507 BREAST MASS 4
508 CARDIAC MURMUR 4
509 CATHETERISATION CARDIAC 4
510 CHOLECYSTITIS 4
511 CHOLECYSTITIS CHRONIC 4
512 CHROMATURIA 4
513 COLD SWEAT 4
514 CORONARY ARTERY STENOSIS 4
515 CROHN^S DISEASE 4
516 CYANOSIS 4
517 CYTOMEGALOVIRUS ENTEROCOLITIS 4
518 CYTOMEGALOVIRUS TEST POSITIVE 4
519 DEMENTIA 4
520 DEVELOPMENTAL DELAY 4
521 DISORIENTATION 4
522 DRUG ABUSE 4
523 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4
524 DRUG EXPOSURE DURING PREGNANCY 4
525 DYSARTHRIA 4
526 DYSURIA 4
527 ECZEMA HERPETICUM 4
528 ELECTROLYTE IMBALANCE 4
529 EMBOLIC STROKE 4
530 EPILEPSY 4
531 EUPHORIC MOOD 4
532 EXERCISE TOLERANCE DECREASED 4
533 EXPOSURE DURING PREGNANCY 4
534 EXTRA DOSE ADMINISTERED 4
535 EYE HAEMORRHAGE 4
536 EYELID DISORDER 4
537 FACE OEDEMA 4
538 FACIAL DISCOMFORT 4
539 GALLBLADDER DISORDER 4
540 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4
541 GASTRIC CANCER 4
542 GLAUCOMA 4
543 HEAD DISCOMFORT 4
544 HOSPITALISATION 4
545 HYPERAMMONAEMIA 4
546 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4
547 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4
548 INITIAL INSOMNIA 4
549 INJECTION SITE INDURATION 4
550 INJECTION SITE RASH 4
551 INTERNAL HAEMORRHAGE 4
552 INTERNATIONAL NORMALISED RATIO DECREASED 4
553 IRRITABLE BOWEL SYNDROME 4
554 KERATOCONUS 4
555 LETHARGY 4
556 LICHENIFICATION 4
557 LIP INJURY 4
558 LUNG NEOPLASM MALIGNANT 4
559 LYMPHOCYTE COUNT DECREASED 4
560 MOUTH ULCERATION 4
561 NASAL DISCOMFORT 4
562 NEOPLASM PROGRESSION 4
563 NEPHROGENIC ANAEMIA 4
564 OBSTRUCTION 4
565 PAIN IN JAW 4
566 PARONYCHIA 4
567 PERIORBITAL SWELLING 4
568 PNEUMONITIS 4
569 POST PROCEDURAL COMPLICATION 4
570 PROCEDURAL PAIN 4
571 PRODUCT CONTAINER ISSUE 4
572 PROTHROMBIN TIME PROLONGED 4
573 PULMONARY EMBOLISM 4
574 PULMONARY TOXICITY 4
575 REBOUND EFFECT 4
576 RED BLOOD CELL COUNT DECREASED 4
577 RENAL FAILURE ACUTE 4
578 RESPIRATORY TRACT CONGESTION 4
579 RIB FRACTURE 4
580 ROTATOR CUFF SYNDROME 4
581 SHOCK 4
582 SINUSITIS BACTERIAL 4
583 SKIN LACERATION 4
584 SKIN LESION 4
585 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4
586 SPINAL OPERATION 4
587 SYNCOPE 4
588 TENDERNESS 4
589 THERAPY PARTIAL RESPONDER 4
590 THROAT TIGHTNESS 4
591 THROMBOSIS 4
592 THYROIDITIS 4
593 TOXIC EPIDERMAL NECROLYSIS 4
594 TOXIC SKIN ERUPTION 4
595 TUMOUR LYSIS SYNDROME 4
596 TYMPANIC MEMBRANE PERFORATION 4
597 UNEVALUABLE EVENT 4
598 ABNORMAL SENSATION IN EYE 3
599 ACCIDENT 3
600 ACIDOSIS 3
601 ACNE 3
602 ANAPHYLACTOID REACTION 3
603 ANGER 3
604 ANGIOEDEMA 3
605 ANKYLOSING SPONDYLITIS 3
606 ARTHROPOD STING 3
607 ATRIOVENTRICULAR BLOCK COMPLETE 3
608 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3
609 AUTOIMMUNE HEPATITIS 3
610 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3
611 AZOTAEMIA 3
612 BLOOD BETA-D-GLUCAN INCREASED 3
613 BLOOD GLUCOSE DECREASED 3
614 BLOOD THYROID STIMULATING HORMONE INCREASED 3
615 BLOOD URINE PRESENT 3
616 BONE MARROW OEDEMA 3
617 BONE PAIN 3
618 BRAIN OEDEMA 3
619 BRONCHIAL HYPERREACTIVITY 3
620 CAESAREAN SECTION 3
621 CARDIAC ARREST 3
622 CARDIAC FAILURE ACUTE 3
623 CARDIOVASCULAR DISORDER 3
624 CARDIOVASCULAR SYMPTOM 3
625 CIRCULATORY COLLAPSE 3
626 CLEFT PALATE 3
627 COLITIS 3
628 COLITIS ULCERATIVE 3
629 CONCOMITANT DISEASE AGGRAVATED 3
630 CONCOMITANT DISEASE PROGRESSION 3
631 CORYNEBACTERIUM SEPSIS 3
632 CRANIOSYNOSTOSIS 3
633 CYST 3
634 CYTOPENIA 3
635 DEFAECATION URGENCY 3
636 DELUSION 3
637 DEVICE FAILURE 3
638 DEVICE MALFUNCTION 3
639 DIABETIC KETOACIDOSIS 3
640 DIARRHOEA HAEMORRHAGIC 3
641 DISORDER OF ORBIT 3
642 DISTURBANCE IN ATTENTION 3
643 DRUG EFFECT DECREASED 3
644 DRUG EFFECT INCOMPLETE 3
645 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
646 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
647 DYSMORPHISM 3
648 EATING DISORDER 3
649 EMBOLISM 3
650 EMOTIONAL DISORDER 3
651 EOSINOPHILIA 3
652 EXPOSURE VIA SKIN CONTACT 3
653 EYELID MARGIN CRUSTING 3
654 FAECES SOFT 3
655 FIBULA FRACTURE 3
656 FOOT DEFORMITY 3
657 FRACTURE 3
658 FULMINANT TYPE 1 DIABETES MELLITUS 3
659 FUNGAL SKIN INFECTION 3
660 GASTROENTERITIS VIRAL 3
661 GASTROINTESTINAL INFLAMMATION 3
662 GENERALISED TONIC-CLONIC SEIZURE 3
663 GINGIVITIS 3
664 GLOSSITIS 3
665 GLYCOSYLATED HAEMOGLOBIN INCREASED 3
666 HAEMOGLOBIN INCREASED 3
667 HAEMOLYTIC ANAEMIA 3
668 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3
669 HEPATIC CIRRHOSIS 3
670 HEPATITIS 3
671 HEPATOCELLULAR CARCINOMA 3
672 HIP FRACTURE 3
673 HYPERBILIRUBINAEMIA 3
674 HYPERTONIC BLADDER 3
675 HYPERTRIGLYCERIDAEMIA 3
676 HYPOACUSIS 3
677 HYPOALBUMINAEMIA 3
678 HYPOCALCAEMIA 3
679 HYSTERECTOMY 3
680 IMMUNE-MEDIATED MYOCARDITIS 3
681 INFUSION SITE DISCOMFORT 3
682 INFUSION SITE EXTRAVASATION 3
683 INFUSION SITE IRRITATION 3
684 INJECTION SITE DISCOLOURATION 3
685 INJECTION SITE URTICARIA 3
686 JOINT INJURY 3
687 JOINT STIFFNESS 3
688 LIPASE INCREASED 3
689 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3
690 LOWER RESPIRATORY TRACT INFECTION 3
691 LYMPHOMA 3
692 MANUFACTURING ISSUE 3
693 MENOPAUSAL SYMPTOMS 3
694 MENTAL DISORDER 3
695 METASTASES TO LUNG 3
696 MUSCULOSKELETAL DISCOMFORT 3
697 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3
698 MYOCLONUS 3
699 NASAL POLYPS 3
700 NEPHROGENIC SYSTEMIC FIBROSIS 3
701 NERVOUS SYSTEM DISORDER 3
702 NOCTURIA 3
703 OESOPHAGEAL CANDIDIASIS 3
704 OESOPHAGITIS 3
705 ORAL INFECTION 3
706 ORAL MUCOSA EROSION 3
707 ORAL PAIN 3
708 ORGANISING PNEUMONIA 3
709 OTITIS EXTERNA 3
710 PANCREATITIS ACUTE 3
711 PARANASAL CYST 3
712 PERIPHERAL COLDNESS 3
713 PERITONITIS 3
714 PHLEBITIS 3
715 PHYSICAL DECONDITIONING 3
716 PIERRE ROBIN SYNDROME 3
717 POOR QUALITY SLEEP 3
718 PREGNANCY 3
719 PRODUCT CLOSURE REMOVAL DIFFICULT 3
720 PRODUCT PHYSICAL ISSUE 3
721 PULMONARY HYPERTENSION 3
722 PUNCTATE KERATITIS 3
723 PYELONEPHRITIS 3
724 RECTAL CANCER 3
725 RECTAL HAEMORRHAGE 3
726 RED CELL DISTRIBUTION WIDTH INCREASED 3
727 RESPIRATORY TRACT IRRITATION 3
728 ROSACEA 3
729 RUBBER SENSITIVITY 3
730 SACROILIITIS 3
731 SCLERODERMA RENAL CRISIS 3
732 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3
733 SINUS OPERATION 3
734 SKIN DISORDER 3
735 SKIN INFECTION 3
736 SKIN SWELLING 3
737 SKIN WARM 3
738 SKIN WEEPING 3
739 STAPHYLOCOCCAL SEPSIS 3
740 SUPRAVENTRICULAR TACHYCARDIA 3
741 THALAMUS HAEMORRHAGE 3
742 THERAPEUTIC RESPONSE UNEXPECTED 3
743 THERAPY CESSATION 3
744 THROMBOTIC CEREBRAL INFARCTION 3
745 THYROIDITIS SUBACUTE 3
746 TIBIA FRACTURE 3
747 TORTICOLLIS 3
748 TYPE 1 DIABETES MELLITUS 3
749 ULCER 3
750 URINARY INCONTINENCE 3
751 UROSEPSIS 3
752 VULVOVAGINAL MYCOTIC INFECTION 3
753 WEIGHT FLUCTUATION 3
754 WHITE BLOOD CELLS URINE POSITIVE 3
755 WRIST FRACTURE 3
756 ABASIA 2
757 ABDOMINAL PAIN LOWER 2
758 ABNORMAL DREAMS 2
759 ABSCESS 2
760 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2
761 ACUTE RESPIRATORY DISTRESS SYNDROME 2
762 ACUTE RESPIRATORY FAILURE 2
763 ACUTE SINUSITIS 2
764 ADMINISTRATION SITE PAIN 2
765 ADMINISTRATION SITE SWELLING 2
766 ADULT T-CELL LYMPHOMA/LEUKAEMIA 2
767 ADVERSE REACTION 2
768 AGEUSIA 2
769 AGRANULOCYTOSIS 2
770 ALLERGY TO ANIMAL 2
771 ALLERGY TO ARTHROPOD BITE 2
772 ALOPECIA UNIVERSALIS 2
773 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2
774 ANAL ABSCESS 2
775 ANAL FISSURE 2
776 ANGINA PECTORIS 2
777 ANTITHROMBIN III DECREASED 2
778 ANURIA 2
779 AORTIC DISSECTION 2
780 AORTIC VALVE CALCIFICATION 2
781 AORTIC VALVE STENOSIS 2
782 AORTIC VALVE THICKENING 2
783 APPLICATION SITE ERYTHEMA 2
784 APPLICATION SITE PAIN 2
785 APPLICATION SITE PRURITUS 2
786 ARTHROPOD BITE 2
787 ASPERGILLUS TEST POSITIVE 2
788 ATYPICAL FEMUR FRACTURE 2
789 ATYPICAL PNEUMONIA 2
790 BACTERIAL SEPSIS 2
791 BASAL CELL CARCINOMA 2
792 BIOPSY BONE MARROW 2
793 BLADDER DISORDER 2
794 BLEPHARITIS 2
795 BLOOD ALBUMIN DECREASED 2
796 BLOOD CREATININE DECREASED 2
797 BLOOD PH DECREASED 2
798 BLOOD PHOSPHORUS DECREASED 2
799 BLOOD POTASSIUM INCREASED 2
800 BLOOD PRESSURE DIASTOLIC DECREASED 2
801 BLOOD PRESSURE IMMEASURABLE 2
802 BLOOD SODIUM DECREASED 2
803 BLOOD TRIGLYCERIDES INCREASED 2
804 BONE DENSITY DECREASED 2
805 BONE MARROW FAILURE 2
806 BOWEL MOVEMENT IRREGULARITY 2
807 BRACHYCEPHALY 2
808 BRAIN OPERATION 2
809 BREAST CANCER FEMALE 2
810 BURSITIS 2
811 C-REACTIVE PROTEIN ABNORMAL 2
812 CARDIAC FAILURE CHRONIC 2
813 CARDIAC FLUTTER 2
814 CARDIOMEGALY 2
815 CARDIOMYOPATHY 2
816 CENTRAL VISION LOSS 2
817 CERVICOBRACHIAL SYNDROME 2
818 CHOKING 2
819 CHOLANGITIS ACUTE 2
820 CHOLANGITIS SCLEROSING 2
821 CHOLECYSTECTOMY 2
822 CHOLECYSTITIS ACUTE 2
823 CHYLOTHORAX 2
824 CLOSTRIDIUM DIFFICILE COLITIS 2
825 COELIAC DISEASE 2
826 COLITIS ISCHAEMIC 2
827 COLON CANCER 2
828 COMPRESSION FRACTURE 2
829 COMPUTERISED TOMOGRAM ABNORMAL 2
830 CONCUSSION 2
831 CONTINUOUS HAEMODIAFILTRATION 2
832 CORONARY ARTERY DISEASE 2
833 CREPITATIONS 2
834 CUSHING^S SYNDROME 2
835 CYSTIC FIBROSIS 2
836 CYTOMEGALOVIRUS VIRAEMIA 2
837 DACRYOCYSTITIS 2
838 DANDRUFF 2
839 DEAFNESS NEUROSENSORY 2
840 DECREASED ACTIVITY 2
841 DEEP BRAIN STIMULATION 2
842 DERMATITIS 2
843 DERMATITIS ACNEIFORM 2
844 DERMATITIS BULLOUS 2
845 DERMATOMYOSITIS 2
846 DEVICE DIFFICULT TO USE 2
847 DEVICE DISLOCATION 2
848 DEVICE PHYSICAL PROPERTY ISSUE 2
849 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2
850 DIPLOPIA 2
851 DISABILITY 2
852 DISEASE RECURRENCE 2
853 DISSEMINATED TUBERCULOSIS 2
854 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2
855 DRUG ADMINISTERED IN WRONG DEVICE 2
856 DRUG LEVEL INCREASED 2
857 DRUG TOLERANCE 2
858 DRY THROAT 2
859 DUODENAL NEOPLASM 2
860 DUODENAL ULCER HAEMORRHAGE 2
861 DYSMENORRHOEA 2
862 DYSSTASIA 2
863 EAR PRURITUS 2
864 EJECTION FRACTION DECREASED 2
865 ELECTROCARDIOGRAM ABNORMAL 2
866 ELECTROCARDIOGRAM QT SHORTENED 2
867 EMPHYSEMATOUS CYSTITIS 2
868 ENCEPHALOMALACIA 2
869 END STAGE RENAL DISEASE 2
870 ENTEROCOLITIS 2
871 EOSINOPHIL COUNT DECREASED 2
872 EOSINOPHILIC PNEUMONIA 2
873 EPIDERMAL NECROSIS 2
874 ERYSIPELAS 2
875 EXOPHTHALMOS 2
876 EYE OEDEMA 2
877 EYE OPERATION 2
878 EYELID BLEEDING 2
879 EYELID EXFOLIATION 2
880 FACIAL BONES FRACTURE 2
881 FAMILIAL MEDITERRANEAN FEVER 2
882 FEELING COLD 2
883 FEMORAL PULSE ABNORMAL 2
884 FLATULENCE 2
885 FLUID INTAKE REDUCED 2
886 FOLLICULITIS 2
887 FOOD ALLERGY 2
888 FOOD CRAVING 2
889 FOOD REFUSAL 2
890 FURUNCLE 2
891 GALLBLADDER INJURY 2
892 GASTRITIS EROSIVE 2
893 GASTROENTERITIS NOROVIRUS 2
894 GASTROINTESTINAL BACTERIAL INFECTION 2
895 GASTROINTESTINAL OEDEMA 2
896 GENERALISED ERYTHEMA 2
897 GENERALISED OEDEMA 2
898 GESTATIONAL DIABETES 2
899 GINGIVAL BLEEDING 2
900 GLOMERULAR FILTRATION RATE DECREASED 2
901 GLUCOSE TOLERANCE IMPAIRED 2
902 GOUTY TOPHUS 2
903 GRANULOMA 2
904 GROIN PAIN 2
905 GUILLAIN-BARRE SYNDROME 2
906 HAEMATOCRIT DECREASED 2
907 HAEMATOMA 2
908 HAEMOGLOBIN ABNORMAL 2
909 HAEMORRHAGE SUBCUTANEOUS 2
910 HAEMORRHOIDAL HAEMORRHAGE 2
911 HAIR COLOUR CHANGES 2
912 HAIR TEXTURE ABNORMAL 2
913 HAND FRACTURE 2
914 HEART FAILURE WITH PRESERVED EJECTION FRACTION 2
915 HEART RATE IRREGULAR 2
916 HEMIPLEGIA 2
917 HEPATIC CYST 2
918 HEPATIC ENCEPHALOPATHY 2
919 HEPATITIS B 2
920 HEPATORENAL SYNDROME 2
921 HERNIA 2
922 HIATUS HERNIA 2
923 HICCUPS 2
924 HYPERACUSIS 2
925 HYPERAESTHESIA 2
926 HYPERCAPNIA 2
927 HYPERLACTACIDAEMIA 2
928 HYPERLIPIDAEMIA 2
929 HYPERPLASIA 2
930 HYPERVENTILATION 2
931 HYPERVOLAEMIA 2
932 HYPOAESTHESIA ORAL 2
933 HYPOGONADISM 2
934 HYPOMAGNESAEMIA 2
935 IMMOBILISATION SYNDROME 2
936 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2
937 IMMUNOSUPPRESSION 2
938 IMPAIRED DRIVING ABILITY 2
939 IMPLANT SITE REACTION 2
940 IMPULSIVE BEHAVIOUR 2
941 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2
942 INCOHERENT 2
943 INCORRECT DOSAGE ADMINISTERED 2
944 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 2
945 INFECTED CYST 2
946 INFUSION SITE DISCOLOURATION 2
947 INFUSION SITE MASS 2
948 INFUSION SITE RASH 2
949 INGUINAL HERNIA 2
950 INJECTION SITE DRYNESS 2
951 INJECTION SITE INFECTION 2
952 INJECTION SITE IRRITATION 2
953 INJECTION SITE SCAB 2
954 INJECTION SITE SCAR 2
955 INJECTION SITE ULCER 2
956 INJECTION SITE VESICLES 2
957 INTENTIONAL PRODUCT MISUSE 2
958 INTRAOCULAR PRESSURE INCREASED 2
959 JOINT EFFUSION 2
960 JUGULAR VEIN THROMBOSIS 2
961 LAZINESS 2
962 LISTLESS 2
963 LIVER FUNCTION TEST INCREASED 2
964 LUMBAR SPINAL STENOSIS 2
965 LUNG ABSCESS 2
966 LUNG INFECTION 2
967 LYMPHOCYTE COUNT INCREASED 2
968 LYMPHOCYTIC INFILTRATION 2
969 MACULAR DEGENERATION 2
970 MADAROSIS 2
971 MARASMUS 2
972 MELANOCYTIC NAEVUS 2
973 MENINGITIS ASEPTIC 2
974 MENOPAUSE 2
975 MENTAL IMPAIRMENT 2
976 MENTAL STATUS CHANGES 2
977 METABOLIC ENCEPHALOPATHY 2
978 METABOLIC SURGERY 2
979 METASTASES TO BONE 2
980 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2
981 MITRAL VALVE CALCIFICATION 2
982 MITRAL VALVE PROLAPSE 2
983 MITRAL VALVE THICKENING 2
984 MOUTH SWELLING 2
985 MUCOSAL DRYNESS 2
986 MULTI-ORGAN FAILURE 2
987 MULTIPLE SCLEROSIS RELAPSE 2
988 MULTIPLE-DRUG RESISTANCE 2
989 MUSCLE HAEMORRHAGE 2
990 MUSCLE TWITCHING 2
991 MUSCULOSKELETAL CHEST PAIN 2
992 MYASTHENIA GRAVIS 2
993 MYCOTIC ALLERGY 2
994 MYDRIASIS 2
995 MYELOFIBROSIS 2
996 MYELOPATHY 2
997 NAIL DISORDER 2
998 NASAL DRYNESS 2
999 NASAL SEPTUM DEVIATION 2